PRIMARY STUDY

Immunomodulation by cannabinoids: Current uses, mechanisms, and identification of data gaps to be addressed for additional therapeutic application

Key Findings:  This review summarizes preclinical and clinical evidence supporting the immunomodulatory potential of cannabinoids and cannabinoid-based therapeutics targeting CB1 and CB2 receptors in immune-mediated diseases, highlighting key findings, genetic insights, and critical data gaps for future research.